Immupharma falls as losses persist
Shares in AIM-listed drug discovery Immupharma dropped by 5.41% after it reported a broadly flat loss for the half year ended 30th June.
Shares in AIM-listed drug discovery Immupharma dropped by 5.41% after it reported a broadly flat loss for the half year ended 30th June.
Business services firm Christie Group saw its shares drop by 5.31% after profits before tax dropped by 50% for the six months ended 30th June.
The share price of AIM-listed electronics manufacturer Solid State climbed by 3.72% after winning a contract for a US rail infrastructure project.
Shares in FTSE 250 residential property firm Grainger rose 1.22% after it said that rental income was up by 3.4% over the year to date.
AIM-listed financial services firm Numis saw its share price drop by 8.28% after it issued a trading statement for the year ended 30th September.
Shares in AIM-listed mining investor Cadence Minerals tumbled 4.46% as it posted a loss before tax during the first half.
The price of shares in Imperial Brands dropped by 10.33% after the company cut its guidance for the year ending 30th September.
FTSE 250 catering specialist SSP saw its share price fall by 5.24% after it issued a pre-close statement for the year ending 30th September.
AIM-listed Hardide watched its share price rise by 2.28% as it said that its revenues for the year ending 30th September would be ahead of expectations.
The price of shares in defence and aerospace company Babcock International has risen by 4.43% after confirmed it was on track to meet full year guidance.